{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:03:44Z","timestamp":1791493424301,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cpm.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T01:46:58Z","timestamp":1459043218000},"page":"305-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Onychomycosis"],"prefix":"10.1016","volume":"33","author":[{"given":"Tracey C.","family":"Vlahovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpm.2016.02.001_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A\u00a0large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2016.02.001_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","article-title":"Toenail onychomycosis: an important global disease burden","volume":"35","author":"Thomas","year":"2010","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.cpm.2016.02.001_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13693780601070107","article-title":"Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades","volume":"45","author":"Borman","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.cpm.2016.02.001_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2340\/00015555-0507","article-title":"Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period","volume":"88","author":"Saunte","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.cpm.2016.02.001_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0733-8635(18)30884-2","article-title":"Onychomycosis","volume":"3","author":"Zaias","year":"1985","journal-title":"Dermatol Clin"},{"issue":"11","key":"10.1016\/j.cpm.2016.02.001_bib6","first-page":"762","article-title":"Onychomycosis: current trends in diagnosis and treatment","volume":"88","author":"Westerberg","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.cpm.2016.02.001_bib7","first-page":"31","article-title":"Onychomycosis in children: an overview","volume":"2","author":"Gupta","year":"2003","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","article-title":"Onychomycosis: a proposed revision of the clinical classification","volume":"65","author":"Hay","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 65","key":"10.1016\/j.cpm.2016.02.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.149.s65.4.x","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"149","author":"Faergemann","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.cpm.2016.02.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and review of the literature on therapy","volume":"57","author":"Murphy","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2 Suppl 1","key":"10.1016\/j.cpm.2016.02.001_bib11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.12788\/j.sder.0015","article-title":"Diagnosis, clinical implications, and complications of onychomycosis","volume":"32","author":"Rich","year":"2013","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.cpm.2016.02.001_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0950-3579(87)80005-5","article-title":"Seronegative arthropathies in the foot","volume":"1","author":"Moll","year":"1987","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.0007-0963.2004.05871.x","article-title":"Onychomycosis: the development of a clinical diagnostic aid for toenail disease. Part I. Establishing discriminating historical and clinical features","volume":"150","author":"Fletcher","year":"2004","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.cpm.2016.02.001_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1067\/S0190-9622(03)01480-4","article-title":"Comparison of diagnostic methods in the evaluation of onychomycosis","volume":"49","author":"Weinberg","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.cpm.2016.02.001_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2133.2003.05029.x","article-title":"Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings","volume":"148","author":"Reisberger","year":"2003","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.cpm.2016.02.001_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7547\/87507315-91-7-351","article-title":"Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques","volume":"91","author":"Borkowski","year":"2001","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"key":"10.1016\/j.cpm.2016.02.001_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0190-9622(96)90062-6","article-title":"Diagnostic techniques for confirming onychomycosis","volume":"35","author":"Elewski","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib18","first-page":"52","article-title":"Polymerase chain reaction in the diagnosis of onychomycosis","volume":"14","author":"Arca","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib19","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0190-9622(08)81836-1","article-title":"Treatment of onychomycosis: traditional approaches","volume":"29","author":"Pierard","year":"1993","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/jcm.31.3.615-621.1993","article-title":"Detection of aspergillus fumigatus by polymerase chain reaction","volume":"31","author":"Spreadbury","year":"1993","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cpm.2016.02.001_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/jcm.30.4.894-900.1992","article-title":"Isolation and characterization of a species-specific DNA fragment for detection of Candida albicans by polymerase chain reaction","volume":"30","author":"Miyakawa","year":"1992","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cpm.2016.02.001_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1139\/m84-091","article-title":"25S ribosomal RNA homologies of basidiomycetous yeasts: taxonomic and phylogenetic implications","volume":"30","author":"Baharaeen","year":"1984","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.cpm.2016.02.001_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2340\/00015555-0077","article-title":"18S rDNA polymerase chain reaction and sequencing in onychomycosis diagnostics","volume":"86","author":"Walberg","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cpm.2016.02.001_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bjd.13358","article-title":"British Association of Dermatologists\u2019 guidelines for the management of onychomycosis 2014","volume":"171","author":"Ameen","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ics.12142","article-title":"Transungual delivery: deliberations and creeds","volume":"36","author":"Thatai","year":"2014","journal-title":"Int J Cosmet Sci"},{"key":"10.1016\/j.cpm.2016.02.001_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","article-title":"Drug permeation through the three layers of the human nail plate","volume":"51","author":"Kobayashi","year":"1999","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.cpm.2016.02.001_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7547\/87507315-90-10-495","article-title":"Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States","volume":"90","author":"Gupta","year":"2000","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"10","key":"10.1016\/j.cpm.2016.02.001_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7547\/87507315-90-10-491","article-title":"The dermatopharmacologic profile of ciclopirox 8% nail lacquer","volume":"90","author":"Bohn","year":"2000","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.cpm.2016.02.001_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/geronj\/10.4.401","article-title":"Studies of growth throughout the lifespan in Japanese: growth and size of nails and their relationship to age, sex, heredity, and other factors","volume":"10","author":"Hamilton","year":"1955","journal-title":"J\u00a0Gerontol"},{"issue":"1","key":"10.1016\/j.cpm.2016.02.001_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent for the treatment of onychomycosis: results from two randomized phase 3 studies","volume":"73","author":"Elewski","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase 3 multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib32","first-page":"1394","article-title":"Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space","volume":"13","author":"Elewski","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"8","key":"10.1016\/j.cpm.2016.02.001_bib33","first-page":"859","article-title":"The presence of an air gap between the nail plate and nail bed in onychomycosis patients: treatment implications for topical therapy","volume":"14","author":"Gupta","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.cpm.2016.02.001_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/0378-6323.18941","article-title":"Nail changes and disorders among the elderly","volume":"71","author":"Singh","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.cpm.2016.02.001_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","article-title":"Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2016.02.001_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","article-title":"Treatment options\u2014development of consensus guidelines","volume":"19","author":"Lecha","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpm.2016.02.001_bib37","unstructured":"Jublia (efinaconazole topical solution, 10%) [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals LLC; 2014."},{"issue":"9","key":"10.1016\/j.cpm.2016.02.001_bib38","first-page":"45","article-title":"Penetration of (14C)-Efinaconazole solution does not appear to be influenced by nail polish","volume":"7","author":"Zeichner","year":"2014","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"7","key":"10.1016\/j.cpm.2016.02.001_bib39","first-page":"675","article-title":"In\u00a0vitro nail penetration of tavaborole topical solution, 5% through nail polish on ex\u00a0vivo human fingernails","volume":"14","author":"Vlahovic","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib40","first-page":"339","article-title":"Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis","volume":"97","author":"Del Rosso","year":"1997","journal-title":"J\u00a0Am Osteopath Assoc"},{"issue":"Supp 56","key":"10.1016\/j.cpm.2016.02.001_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2133.1999.00008.x","article-title":"L.I.ON. Study: efficacy and tolerability of continuous terbinafine compared to intermittent itraconazole in the treatment of toenail onychomycosis","volume":"141","author":"Sigurgeirsson","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","article-title":"An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis","volume":"23","author":"Baran","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpm.2016.02.001_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","article-title":"A\u00a0multicenter, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis","volume":"157","author":"Baran","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.00043.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.cpm.2016.02.001_bib45","first-page":"197","article-title":"Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10%","volume":"96","author":"Rosen","year":"2015","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.cpm.2016.02.001_bib46","first-page":"24","article-title":"Efinaconazole topical solution, 10% for the treatment of mild and moderate toenail onychomycosis","volume":"8","author":"Rodriguez","year":"2015","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2016.02.001_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7547\/14-088","article-title":"Efinaconazole topical solution, 10%: efficacy in onychomycosis patients with co-existing tinea pedis","volume":"105","author":"Markinson","year":"2015","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"1","key":"10.1016\/j.cpm.2016.02.001_bib48","first-page":"58","article-title":"Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early","volume":"14","author":"Rich","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09546630600965004","article-title":"The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis","volume":"18","author":"Potter","year":"2007","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.cpm.2016.02.001_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.jfas.2008.12.012","article-title":"Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial","volume":"48","author":"Malay","year":"2009","journal-title":"J\u00a0Foot Ankle Surg"},{"key":"10.1016\/j.cpm.2016.02.001_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7547\/0960465","article-title":"Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial","volume":"96","author":"Jennings","year":"2006","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"key":"10.1016\/j.cpm.2016.02.001_bib52","doi-asserted-by":"crossref","DOI":"10.7547\/14-170.1","article-title":"Diagnosis and management of onychomycosis: perspectives from a joint podiatry-dermatology roundtable","author":"Markinson","year":"2015","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"5","key":"10.1016\/j.cpm.2016.02.001_bib53","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the treatment of onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/lsm.22211","article-title":"A\u00a0review of lasers and light for the treatment of onychomycosis","volume":"46","author":"Ortiz","year":"2014","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.cpm.2016.02.001_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1757-1146-7-34","article-title":"The effectiveness of lasers in the treatment of onychomycosis: a systematic review","volume":"7","author":"Bristow","year":"2014","journal-title":"J\u00a0Foot Ankle Res"},{"key":"10.1016\/j.cpm.2016.02.001_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2133.2001.00047.x","article-title":"The rationale for combination therapy","volume":"145","author":"Evans","year":"2001","journal-title":"Br J Dermatol"},{"issue":"Suppl 65","key":"10.1016\/j.cpm.2016.02.001_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.149.s65.2.x","article-title":"Combination therapy for onychomycosis","volume":"149","author":"Olafsson","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630500420183","article-title":"Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis","volume":"16","author":"Avner","year":"2005","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.cpm.2016.02.001_bib59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2133.2003.05381.x","article-title":"A\u00a0randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis","volume":"149","author":"Rigopoulos","year":"2003","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.cpm.2016.02.001_bib60","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/DSS.0000000000000157","article-title":"Combined oral terbinafine and long-pulsed 1,064-nm Nd: YAG laser treatment is more effective for onychomycosis than either treatment alone","volume":"40","author":"Xu","year":"2014","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.cpm.2016.02.001_bib61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2133.2007.08014.x","article-title":"Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial","volume":"157","author":"Grover","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0378-6323.95444","article-title":"Nail avulsion: indications and methods (surgical nail avulsion)","volume":"78","author":"Pandhi","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl 65","key":"10.1016\/j.cpm.2016.02.001_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2133.149.s65.5.x","article-title":"Onychomycosis in clinical practice: factors contributing to recurrence","volume":"149","author":"Scher","year":"2003","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2016.02.001_bib64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1439-0507.2010.01928.x","article-title":"Cure rate, duration required for complete cure and recurrence rate of onychomycosis according to clinical factors in Korean patients","volume":"54","author":"Ko","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.cpm.2016.02.001_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2340\/00015555777071","article-title":"Long-term results of patients with onychomycosis treated with itraconazole","volume":"77","author":"Heikkila","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cpm.2016.02.001_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1440-0960.1998.tb01237.x","article-title":"Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine","volume":"39","author":"Watson","year":"1998","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/09546634.2011.579082","article-title":"A\u00a0meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole","volume":"23","author":"Yin","year":"2012","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.cpm.2016.02.001_bib69","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1468-3083.2009.03547.x","article-title":"Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years","volume":"24","author":"Sigurgeirsson","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.cpm.2016.02.001_bib70","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2005.06.019","article-title":"Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%","volume":"53","author":"Warshaw","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1757-1626-2-70","article-title":"Preventing long term relapsing tinea unguium with topical anti-fungal cream: a case report","volume":"2","author":"Arroll","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.cpm.2016.02.001_bib72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/pdia.2014.40968","article-title":"Amorolfine vs. ciclopirox \u2013 lacquers for the treatment of onychomycosis","volume":"32","author":"Tabara","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"issue":"11","key":"10.1016\/j.cpm.2016.02.001_bib74","first-page":"1338","article-title":"Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in\u00a0vivo fungicidal activity in the human nails","volume":"13","author":"Sakamoto","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib75","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.12594","article-title":"A\u00a0second look at efficacy criteria for onychomycosis: clinical and mycological cure","volume":"170","author":"Ghannoum","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.cpm.2016.02.001_bib77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jdv.12609","article-title":"Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails","volume":"29","author":"Shemer","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.cpm.2016.02.001_bib78","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/1346-8138.12138","article-title":"Dermatophyte isolation in the socks of patients with tinea pedis and onychomycosis","volume":"40","author":"Bonifaz","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.cpm.2016.02.001_bib79","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1468-3083.2011.04176.x","article-title":"A\u00a0study on the decontamination of insoles colonized by Trichophyton rubrum: effect of terbinafine spray powder 1% and terbinafine spray solution 1%","volume":"26","author":"Feuilhade de Chauvin","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.cpm.2016.02.001_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7547\/1020309","article-title":"Optimization of an infected shoe model for the evaluation of an ultraviolet show sanitizer device","volume":"102","author":"Ghannoum","year":"2012","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.cpm.2016.02.001_bib81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2310\/7750.2012.12068","article-title":"Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?","volume":"17","author":"Gupta","year":"2013","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.cpm.2016.02.001_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09546634.2012.714456","article-title":"Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichphyton mentagrophytes using an in\u00a0vitro test system","volume":"25","author":"Gupta","year":"2014","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.cpm.2016.02.001_bib83","first-page":"352","article-title":"How long do dermatophytes survive in the water of indoor pools?","volume":"165","author":"Fisher","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.cpm.2016.02.001_bib84","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11046-010-9347-9","article-title":"Infection risk by dermatophytes during storage and after domestic laundry and their temperature-dependent inactivation","volume":"171","author":"Hammer","year":"2011","journal-title":"Mycopathologia"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842216300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842216300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:56:41Z","timestamp":1760209001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842216300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0891842216300131"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2016.02.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736007611.793561570","asserted-by":"object"}]},"ISSN":["0891-8422"],"issn-type":[{"value":"0891-8422","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}